SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-179548
Filing Date
2015-05-08
Accepted
2015-05-08 16:06:03
Documents
12
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d892453d10q.htm 10-Q 230419
2 EX-10.1 d892453dex101.htm EX-10.1 41720
3 EX-31.1 d892453dex311.htm EX-31.1 6370
4 EX-31.2 d892453dex312.htm EX-31.2 6594
5 EX-32.1 d892453dex321.htm EX-32.1 3080
6 EX-32.2 d892453dex322.htm EX-32.2 3265
  Complete submission text file 0001193125-15-179548.txt   2554535

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT cnat-20150331.xml EX-101.INS 288647
8 XBRL TAXONOMY EXTENSION SCHEMA cnat-20150331.xsd EX-101.SCH 22763
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cnat-20150331_cal.xml EX-101.CAL 40749
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cnat-20150331_def.xml EX-101.DEF 72510
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE cnat-20150331_lab.xml EX-101.LAB 225634
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cnat-20150331_pre.xml EX-101.PRE 153202
Mailing Address 16745 WEST BERNARDO DRIVE Suite 200 San Diego CA 92127
Business Address 16745 WEST BERNARDO DRIVE Suite 200 San Diego CA 92127 (858) 376-2600
Conatus Pharmaceuticals Inc. (Filer) CIK: 0001383701 (see all company filings)

IRS No.: 203183915 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36003 | Film No.: 15846706
SIC: 2834 Pharmaceutical Preparations